Skip to main content

Peer Review reports

From: A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 ( TOP1 ) gene: a study protocol

Original Submission
28 Jan 2015 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Publishing
5 Feb 2015 Editorially accepted
21 Feb 2015 Article published 10.1186/s12885-015-1072-9

You can find further information about peer review here.

Back to article page